Cephalon to acquire Mepha AG
- February 02, 2010
Cephalon, Inc. has signed an agreement to acquire Mepha AG and its subsidiaries for $590 million. The privately-held, Swiss-based Mepha is focused on innovative dosage formulations for both generic and branded ... Read More